| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.084 | 0.1 |